Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CodeLab Capital ASOSL:CODE +5.70%53 3-Year EPS without NRI Growth Rate is 70.20% as of Dec. 2025, which is 1533% above its 10-year median of 4.30. GuruFocus rates OSL:CODE with a GF Score™ of 53/100 and a GF Value™ of kr2.20 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 506 Healthcare Providers & Services companies, CodeLab Capital AS ranks better than 93.08% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 70.20% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 29.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 8 years, the highest 3-Year average EPS without NRI Growth Rate of CodeLab Capital AS was 70.20% per year. The lowest was -43.40% per year. And the median was 4.30% per year.
CodeLab Capital AS (OSL:CODE) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
CodeLab Capital AS 3-Year EPS without NRI Growth Rate Related Terms
OSL:CODE vs VEEV, BTSG, HQY: 3-Year EPS without NRI Growth Rate Comparison
For the Health Information Services subindustry, CodeLab Capital AS's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CodeLab Capital AS 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CodeLab Capital AS's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where CodeLab Capital AS's 3-Year EPS without NRI Growth Rate falls into.
CodeLab Capital AS 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 70.20% mean?
CodeLab Capital AS (OSL:CODE) has a 3-Year EPS without NRI Growth Rate of 70.20% as of Dec. 2025. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for CodeLab Capital AS and its competitors. This is 1533% above median its historical median of 4.30. According to the industry distribution chart, CodeLab Capital AS ranks #35 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 6.9%.
Is CodeLab Capital AS's 3-Year EPS without NRI Growth Rate too high?
CodeLab Capital AS's current 3-Year EPS without NRI Growth Rate of 70.20% is 1533% above median its 10-year median of 4.30. The Healthcare Providers & Services industry median 3-Year EPS without NRI Growth Rate is 11.00. CodeLab Capital AS's value of 70.20% is 538.2% above this industry median. Based on the distribution chart, CodeLab Capital AS ranks #35 out of 506 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, CodeLab Capital AS has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CodeLab Capital AS's 3-Year EPS without NRI Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, CodeLab Capital AS ranks #35 out of 506 companies for 3-Year EPS without NRI Growth Rate. This places CodeLab Capital AS in the top 7% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 11.00. CodeLab Capital AS's value of 70.20% is 538.2% above this benchmark. While the company's 10-year median is 4.30 vs. the industry median of 11.00, CodeLab Capital AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 11.00, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CodeLab Capital AS's current 3-Year EPS without NRI Growth Rate of 70.20% is 538.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for CodeLab Capital AS and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CodeLab Capital AS's current 3-Year EPS without NRI Growth Rate is 70.20%, which is 1533% above median its own 10-year median of 4.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CodeLab Capital AS stock overvalued right now?
Based on GuruFocus' analysis, CodeLab Capital AS (OSL:CODE) is currently considered Significantly Overvalued. The stock's GF Value™ is kr2.20, compared to a current price of kr3.71 — trading 68.6% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 70.20%, which is 1533% above median its 10-year median of 4.30 and 538.2% above the Healthcare Providers & Services industry median of 11.00. CodeLab Capital AS's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For CodeLab Capital AS (OSL:CODE), the current 3-Year EPS without NRI Growth Rate is 70.20% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CodeLab Capital AS (OSL:CODE) Overvalued in 2026?
Based on GuruFocus' analysis, CodeLab Capital AS stock appears to be overvalued.
The current stock price of kr3.71 is trading 68.6% above its estimated GF Value™ of kr2.20.
GuruFocus considers CodeLab Capital AS to be Significantly Overvalued.
Key valuation signals for OSL:CODE:
3-Year EPS without NRI Growth Rate: 70.20% (1533% above median its 10-year median of 4.30)
GF Value™: kr2.20 vs. price of kr3.71 (68.6% above fair value)
Industry Position: 538.2% above the Healthcare Providers & Services median (#35 of 506)
No single metric tells the full story. See the OSL:CODE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CodeLab Capital AS builds and invests in next-generation technology. Its primary objective is to invest in other companies and contribute with capital, network, and operations. CodeLab Capital AS is a holding company that, through its subsidiary, is engaged in making software development tools for the broader B2B market.
53GF Score
Get the complete analysis for OSL:CODE
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:CODE has been successfully added to your 
